drugset / Trial / NCT02206711
Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.
Non-randomizedSingle-groupOpen-labelOther
Summary
The purpose of this study is to assess the pharmacokinetics (PK), metabolism, routes and extent of elimination, safety and tolerability of a single oral dose of \[14C\] BMS-955176 in healthy male subjects. There is no formal research hypothesis to be statistically tested for this study.
Timeline
- Start
- 2014-08-08
- Primary completion
- 2014-09-09
- Completion
- 2014-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-955176 | Other / unclassified | 180 mg | Oral |